South African approval for Biomatrix' Synvisc fluid substitute:
This article was originally published in Clinica
Biomatrix has received approval to market its Synvisc synovial fluid substitute in South Africa. The hylan polymer is used to treat osteoarthritis of the knee and has received approval in various countries, including the US, Europe, Canada and China. Synvisc will be marketed in South Africa by Roche Products.